Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy.

Mennini, Francesco Saverio; Bonanni, Paolo; Bianic, Florence; de Waure, Chiara; Baio, Gianluca; Plazzotta, Giacomo; Uhart, Mathieu; Rinaldi, Alessandro; Largeron, Nathalie

Mennini, Francesco Saverio; Bonanni, Paolo; Bianic, Florence; de Waure, Chiara; Baio, Gianluca; Plazzotta, Giacomo; Uhart, Mathieu; Rinaldi, Alessandro; Largeron, Nathalie.

Afiliação

Mennini FS; Faculty of Economics, Centre for Economic and International Studies (CEIS)-Economic Evaluation and HTA (EEHTA), University of Rome, Rome, Italy.
Bonanni P; Institute for Leadership and Management in Health, Kingston University, London, UK.
Bianic F; Dept. of Health Sciences, University of Florence, Florence, Italy.
de Waure C; Mapi, Nanterre, France.
Baio G; Institute of Public Health, Section of Hygiene, Catholic University of the Sacred Heart, Rome, Italy.
Plazzotta G; University College London, London, UK.
Uhart M; Mapi, Uxbridge, UK.
Rinaldi A; Sanofi Pasteur MSD, Lyon, France.
Largeron N; Sanofi Pasteur MSD, Rome, Italy.

Cost Eff Resour Alloc ; 15: 11, 2017.

Article em En | MEDLINE | ID: mdl-28701899

Palavras-chave

Cervical cancer; Cost-effectiveness; HPV; Italy; Vaccination

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Cost Eff Resour Alloc Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google